Study Comparing In-laboratory Polysomnography Electrocardiogram (PSG ECG) to Simultaneously Recorded In-laboratory ECG on the CPC M1 Device
Completed · Not applicable
Conditions studied: Sleep Disorder
In brief
Research study that will test a portable device (CPC M1) that records: body movement; heart activity (ECG; snoring; and body position during sleep. The Food and Drug Administration (FDA) has not approved this device for use except in a research setting. The purposes of this study are to: a) determine if the ECG data collected using the CPC M1 device is at least as good as the ECG data collected during a diagnostic, in-lab polysomnogram (PSG) (or sleep study) and b) determine if in-home monitoring with the device will provide similar results compared to an in-lab PSG.
Key facts
- Study ID
- NCT01234077
- Run by
- National Jewish Health
- People needed
- 50
- Starts
- 2010-03-01
- Expected to finish
- 2010-09-01
- Last updated by the study team
- 2021-01-19
Who can join
Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Adults (males and females) 18 to 70 years of age with a suspected sleep disorder.
- Subjects or legal guardians are able to verbalize an understanding of the consent form, provide written informed consent, and verbalize willingness to complete study procedures.
- Adequate dexterity to apply and remove the CPC M1 device.
You may not qualify if…
- Patients with atrial fibrillation and ventricular tachycardia.
- Patients with an inability to apply the CPC M1 device.
- Pregnancy.
Where it is running
- National Jewish Health — Denver, Colorado, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.